Tag: cancer
-
Cancer Drug Delivery Through Milk Particles Under Study
A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions.
-
Precision Medicine Technique Devised for Brain Tumors
A process for quickly determining genetic mutations behind brain tumors and delivering a treatment addressing those mutations is shown to extend the survival of lab mice induced with those tumors.
-
Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses.
-
Infographic – U.S. Smoking Rate Hits New Low
These data show fewer than 1 in 6 Americans, or 16 percent, smoked a cigarette in the past week.
-
Merck, Biopharma Partner on Cell-Free Immune System Therapies
Drug maker Merck is acquiring the rights to therapies for cancer and autoimmune disorders based on a technology for developing synthetic proteins from a process that bypasses live cells.
-
RNA Nanoparticles Designed for Brain Cancer Therapy
Medical researchers and material scientists devised a technique for delivering tiny particles of genetic material to the brain, which help lab mice shrink or remove their brain tumors and survive longer.
-
Nanoparticles Shown to Boost Anti-Cancer Immune Cells
A bioengineering lab developed a technique to attach larger quantities of cancer-fighting proteins to immune system cells that in lab mice reduced or eliminated tumors while avoiding harmful side effects.
-
Engineered Polio Virus Tested as Brain Cancer Treatment
Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods.
-
Cancer T-Cell Start-Up Gains $150 Million in IPO
A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock.
-
Engineered T-Cells Tested for Childhood Brain Cancer
A clinical trial is getting underway testing modified T-cells from the immune system in children and young adults with brain tumors that do not respond to other treatments.